Nonmuscle invasive bladder cancer: a primer on immunotherapy

被引：14
|
作者：
Maruf, Mahir [1 ]
Brancato, Sam J. [1 ]
Agarwal, Piyush K. [1 ]
机构：
[1] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA
来源：
CANCER BIOLOGY & MEDICINE | 2016年 / 13卷 / 02期
关键词：
BACILLUS-CALMETTE-GUERIN; TRANSITIONAL-CELL-CARCINOMA; ADENOVIRAL RECEPTOR EXPRESSION; MYCOBACTERIUM-BOVIS; T-CELLS; CARCINOEMBRYONIC ANTIGEN; INTRAVESICAL TREATMENT; UROTHELIAL CARCINOMA; BCG IMMUNOTHERAPY; IMMUNE-RESPONSES;
D O I：
10.20892/j.issn.2095-3941.2016.0020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Intravesical Bacillus Calmette-Guerin (BCG) has long been the gold standard treatment of nonmuscle invasive bladder cancer. Recently, there has been an emergence of novel immunotherapeutic agents, which have shown promise in the treatment of urothelial cell carcinoma. These agents aim to augment, modify, or enhance the immune response. Such strategies include recombinant BCG, monoclonal antibodies, vaccines, gene therapy, and adoptive T-cell therapy. Here, we review the emerging immunotherapeuticsin the treatment of nonmuscle invasive bladder cancer.
引用
收藏
页码：194 / 205
页数：12
相关论文
共 50 条
  • [21] Best practice in the treatment of nonmuscle invasive bladder cancer
    Anastasiadis, Anastasios
    de Reijke, Theo M.
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (01) : 13 - 32
  • [22] New therapies in nonmuscle invasive bladder cancer treatment
    Rayn, Kareem N.
    Hale, Graham R.
    Grave, Gustavo Pena-La
    Agarwal, Piyush K.
    INDIAN JOURNAL OF UROLOGY, 2018, 34 (01) : 11 - 19
  • [23] Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladder
    Di Stasi, Savino M.
    De Carlo, Francesco
    Pagliarulo, Vincenzo
    Masedu, Francesco
    Verri, Cristian
    Celestino, Francesco
    Riedl, Claus
    THERAPEUTIC ADVANCES IN UROLOGY, 2015, 7 (06) : 339 - 350
  • [24] Study for the Therapy of nonmuscle-invasive Bladder Cancer
    Rexer, H.
    UROLOGE, 2014, 53 (06): : 890 - 892
  • [25] Natural biology and management of nonmuscle invasive bladder cancer
    Scarpato, Kristen R.
    Tyson, Mark D.
    Clark, Peter E.
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (03) : 210 - 215
  • [26] SURVIVORSHIP AND THE NEED FOR CANCER NAVIGATION IN NONMUSCLE-INVASIVE BLADDER CANCER
    Honore, Heather H.
    Amiel, Gilad E.
    Lerner, Seth P.
    Latini, David M.
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 57 - 57
  • [27] Genomic landscape of micropapillary nonmuscle-invasive bladder cancer
    Reardon, Brendan
    Mullane, Stephanie A.
    Kim, Jaegil
    Getz, Gad
    Orsola, Anna
    Kwiatkowski, David J.
    Van Allen, Eliezer Mendel
    Bellmunt, Joaquim
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Office-based Management of Nonmuscle Invasive Bladder Cancer
    Meeks, Joshua J.
    Herr, Harry W.
    UROLOGIC CLINICS OF NORTH AMERICA, 2013, 40 (04) : 473 - +
  • [29] Patterns of Questionable Quality Care in Nonmuscle Invasive Bladder Cancer
    Gore, John L.
    Porter, Michael P.
    CANCER, 2010, 116 (11) : 2508 - 2510
  • [30] Bladder cancer mortality after a diagnosis of nonmuscle-invasive bladder carcinoma
    Abdel-Rahman, Omar
    FUTURE ONCOLOGY, 2019, 15 (19) : 2267 - 2275
12345